UnknownNCT07658885

Development, Validation and Clinical Efficacy Evaluation of an AI-based Snake Species Identification System for Snakebite Treatment: a Multicenter Prospective Observational Study

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Trial Details

ConditionSnake Bite
InterventionSSRS system-assisted snake species identification
StatusUnknown
Participants400
Est. Completion20 June 2026
Last Updated22 June 2026

Primary Outcome

Snake species identification (64-class classification) and venomous/non-venomous snake discrimination (binary classification)

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: 1. Adult patients aged ≥18 years, regardless of gender 2. Definite history of snake bite, with time from bite occurrence to first medical visit ≤24 hours 3. The patient or eyewitness can provide digital images of the biting snake (taken by mobile phone, camera, etc.) 4. Voluntarily sign the written informed consent form; for patients with impaired consciousness who cannot sign independently, their legal representative shall sign on their behalf, and a secondary confirmation shall be obtained after the patient regains consciousness 5. Able to cooperate in completing follow-up assessments at discharge and 30 days after injury Exclusion Criteria: * 1\. Unable to provide snake images, or images are severely blurred resulting in complete loss of key identification features 2. Snake species cannot be confirmed by the gold standard (no eyewitnesses, no typical clinical manifestations, cannot be clarified by expert panel consultation) 3. Medical visit exceeds 24 hours and the exact bite time and initial clinical manifestations cannot be determined 4. Complicated with end-stage malignant tumors, severe liver and kidney failure, or other underlying diseases that may significantly affect prognosis judgment 5. Refuse to sign the informed consent form or cannot cooperate in completing follow-up 6. Simultaneously participating in other clinical studies that may affect the results of this study

Trial Sites

Countries

China
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service